Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series

Affiliations

• ¹ Department of Immuno-hematology, Hôpital St-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
• ² Unité de Formation et de Recherche de Médecine, Université Paris Cité, Paris, France.
• ³ Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
• ⁴ Department of Hematology, Hôpital Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France.
• ⁵ Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
• ⁶ Hematology Unit and Amyloidosis Center, University Hospital Limoges, Limoges, France.
• ⁷ Department of Nephrology and Organ Transplantation, University Hospital Toulouse, Toulouse, France.
• ⁸ Department of Nephrology and Amyloidosis Center, University Hospital Poitiers, France.
• ⁹ Department of Hematology, Hôpital St-Vincent de Paul, Lille, France.
• ¹⁰ Department of Internal Medicine V, Amyloidosis Center Heidelberg, University Hospital Heidelberg, Heidelberg, Germany.
• ¹¹ Department of Hematology, University Hospital Lyon Sud, Pierre-Bénite, France.
• ¹² Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Zografou, Greece.